Zolpidem Tartrate

Product NDC
47335-307
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Zolpidem Tartrate
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA204170
Marketing category
ANDA
Substance
ZOLPIDEM TARTRATE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
47335-307-13500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-307-13) 20170515NoHistorical
47335-307-88100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-307-88) 20170515NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
a1faca42-6e46-4586-97ac-050b724e7d2aThese highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM TARTRATE extended-release tablets, for oral use, C-IV Initial U.S. Approval: 1992Aphena Pharma Solutions - Tennessee, LLC2025-06-09Human Prescription Drug Label1
0c64bc71-2e7f-4b15-a8e1-acb8de04395fThese highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM TARTRATE extended-release tablets, for oral use, C-IV Initial U.S. Approval: 1992Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited2023-10-18Human Prescription Drug Label13